Annual EBIT
-$159.45 M
-$68.93 M-76.15%
31 December 2023
Summary:
Syros Pharmaceuticals annual earnings before interest & taxes is currently -$159.45 million, with the most recent change of -$68.93 million (-76.15%) on 31 December 2023. During the last 3 years, it has fallen by -$77.20 million (-93.87%). SYRS annual EBIT is now -1086.80% below its all-time high of -$13.18 million.SYRS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$5.08 M
+$16.86 M+76.83%
30 September 2024
Summary:
Syros Pharmaceuticals quarterly earnings before interest & taxes is currently -$5.08 million, with the most recent change of +$16.86 million (+76.83%) on 30 September 2024. Over the past year, it has increased by +$33.76 million (+86.91%). SYRS quarterly EBIT is now -111.75% below its all-time high of -$2.40 million, reached on 31 March 2024.SYRS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$92.48 M
+$33.76 M+26.74%
30 September 2024
Summary:
Syros Pharmaceuticals TTM earnings before interest & taxes is currently -$92.48 million, with the most recent change of +$33.76 million (+26.74%) on 30 September 2024. Over the past year, it has increased by +$7.55 million (+7.55%). SYRS TTM EBIT is now -1922.86% below its all-time high of -$4.57 million, reached on 31 March 2015.SYRS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -76.2% | +86.9% | +7.5% |
| 3 y3 years | -93.9% | +79.7% | -3.4% |
| 5 y5 years | -156.0% | +75.1% | -24.7% |
SYRS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -93.9% | at low | -111.8% | +91.9% | -11.9% | +42.0% |
| 5 y | 5 years | -156.0% | at low | -111.8% | +91.9% | -31.3% | +42.0% |
| alltime | all time | -1086.8% | at low | -111.8% | +91.9% | -1922.9% | +42.0% |
Syros Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.08 M(-76.8%) | -$92.48 M(-26.7%) |
| June 2024 | - | -$21.95 M(+814.0%) | -$126.24 M(-9.4%) |
| Mar 2024 | - | -$2.40 M(-96.2%) | -$139.28 M(-12.7%) |
| Dec 2023 | -$159.45 M(+76.1%) | -$63.05 M(+62.3%) | -$159.45 M(+59.4%) |
| Sept 2023 | - | -$38.84 M(+11.0%) | -$100.04 M(+10.7%) |
| June 2023 | - | -$34.98 M(+55.0%) | -$90.40 M(+1.7%) |
| Mar 2023 | - | -$22.57 M(+518.8%) | -$88.92 M(-1.8%) |
| Dec 2022 | -$90.52 M(+9.5%) | -$3.65 M(-87.5%) | -$90.52 M(-17.5%) |
| Sept 2022 | - | -$29.20 M(-12.8%) | -$109.70 M(+3.9%) |
| June 2022 | - | -$33.50 M(+38.6%) | -$105.54 M(+12.8%) |
| Mar 2022 | - | -$24.17 M(+5.9%) | -$93.56 M(+13.2%) |
| Dec 2021 | -$82.65 M(+0.5%) | -$22.83 M(-8.8%) | -$82.65 M(-7.6%) |
| Sept 2021 | - | -$25.04 M(+16.4%) | -$89.41 M(+7.3%) |
| June 2021 | - | -$21.52 M(+62.3%) | -$83.36 M(+6.1%) |
| Mar 2021 | - | -$13.26 M(-55.2%) | -$78.55 M(-4.5%) |
| Dec 2020 | -$82.25 M(+9.1%) | -$29.59 M(+55.8%) | -$82.25 M(+16.7%) |
| Sept 2020 | - | -$18.99 M(+13.7%) | -$70.45 M(-1.9%) |
| June 2020 | - | -$16.71 M(-1.5%) | -$71.85 M(-4.6%) |
| Mar 2020 | - | -$16.95 M(-4.7%) | -$75.35 M(-0.0%) |
| Dec 2019 | -$75.37 M | -$17.80 M(-12.7%) | -$75.36 M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$20.39 M(+0.9%) | -$74.16 M(+5.8%) |
| June 2019 | - | -$20.21 M(+19.1%) | -$70.09 M(+8.8%) |
| Mar 2019 | - | -$16.97 M(+2.3%) | -$64.43 M(+3.5%) |
| Dec 2018 | -$62.28 M(+13.9%) | -$16.59 M(+1.6%) | -$62.28 M(+1.7%) |
| Sept 2018 | - | -$16.32 M(+12.2%) | -$61.21 M(+3.9%) |
| June 2018 | - | -$14.55 M(-1.8%) | -$58.93 M(+1.8%) |
| Mar 2018 | - | -$14.82 M(-4.5%) | -$57.89 M(+5.9%) |
| Dec 2017 | -$54.69 M(+14.0%) | -$15.52 M(+10.5%) | -$54.69 M(+8.9%) |
| Sept 2017 | - | -$14.04 M(+3.9%) | -$50.21 M(-0.4%) |
| June 2017 | - | -$13.51 M(+16.4%) | -$50.39 M(+3.0%) |
| Mar 2017 | - | -$11.61 M(+5.1%) | -$48.94 M(+2.0%) |
| Dec 2016 | -$47.96 M(+60.8%) | -$11.04 M(-22.3%) | -$47.96 M(+0.7%) |
| Sept 2016 | - | -$14.22 M(+17.8%) | -$47.61 M(+13.7%) |
| June 2016 | - | -$12.06 M(+13.4%) | -$41.85 M(+16.6%) |
| Mar 2016 | - | -$10.64 M(-0.5%) | -$35.88 M(+20.3%) |
| Dec 2015 | -$29.82 M(+122.0%) | -$10.69 M(+26.3%) | -$29.82 M(+55.9%) |
| Sept 2015 | - | -$8.46 M(+38.9%) | -$19.13 M(+79.3%) |
| June 2015 | - | -$6.09 M(+33.3%) | -$10.67 M(+133.3%) |
| Mar 2015 | - | -$4.57 M | -$4.57 M |
| Dec 2014 | -$13.44 M | - | - |
FAQ
- What is Syros Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual EBIT year-on-year change?
- What is Syros Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly EBIT year-on-year change?
- What is Syros Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals TTM EBIT year-on-year change?
What is Syros Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of SYRS is -$159.45 M
What is the all time high annual EBIT for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual earnings before interest & taxes is -$13.18 M
What is Syros Pharmaceuticals annual EBIT year-on-year change?
Over the past year, SYRS annual earnings before interest & taxes has changed by -$68.93 M (-76.15%)
What is Syros Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of SYRS is -$5.08 M
What is the all time high quarterly EBIT for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$2.40 M
What is Syros Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, SYRS quarterly earnings before interest & taxes has changed by +$33.76 M (+86.91%)
What is Syros Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of SYRS is -$92.48 M
What is the all time high TTM EBIT for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high TTM earnings before interest & taxes is -$4.57 M
What is Syros Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, SYRS TTM earnings before interest & taxes has changed by +$7.55 M (+7.55%)